JPMorgan Chase & Co’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.53M | Sell |
2,125,717
-59,763
| -3% | -$155K | ﹤0.01% | 2623 |
|
|
2025
Q1 | $4.15M | Buy |
2,185,480
+1,913,152
| +703% | +$3.63M | ﹤0.01% | 2795 |
|
|
2024
Q4 | $395K | Buy |
272,328
+227,864
| +512% | +$330K | ﹤0.01% | 4249 |
|
|
2024
Q3 | $81.8K | Sell |
44,464
-1,419
| -3% | -$2.61K | ﹤0.01% | 4799 |
|
|
2024
Q2 | $45.9K | Buy |
45,883
+7,530
| +20% | +$7.53K | ﹤0.01% | 4928 |
|
|
2024
Q1 | $75.9K | Sell |
38,353
-23,979
| -38% | -$47.5K | ﹤0.01% | 4833 |
|
|
2023
Q4 | $97.2K | Sell |
62,332
-407
| -0.6% | -$635 | ﹤0.01% | 4776 |
|
|
2023
Q3 | $124K | Sell |
62,739
-8,425
| -12% | -$16.6K | ﹤0.01% | 4487 |
|
|
2023
Q2 | $226K | Buy |
71,164
+70,757
| +17,385% | +$225K | ﹤0.01% | 4214 |
|
|
2023
Q1 | $1K | Buy |
+407
| New | +$1K | ﹤0.01% | 5631 |
|
|
2022
Q1 | – | Sell |
-23,749
| Closed | -$75K | – | 5745 |
|
|
2021
Q4 | $75K | Buy |
+23,749
| New | +$75K | ﹤0.01% | 4925 |
|